|
GEM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.038600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.437200E-03 |
| Normal-vs-Stage2 |
1.227780E-02 |
| Normal-vs-Stage3 |
4.795000E-03 |
| Normal-vs-Stage4 |
9.093600E-02 |
| Stage1-vs-Stage2 |
6.674000E-01 |
| Stage1-vs-Stage3 |
4.615600E-01 |
| Stage1-vs-Stage4 |
4.096600E-01 |
| Stage2-vs-Stage3 |
9.402000E-01 |
| Stage2-vs-Stage4 |
3.534800E-01 |
| Stage3-vs-Stage4 |
2.372000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.788050E-02 |
| Normal-vs-AfricanAmerican |
8.037300E-03 |
| Normal-vs-Asian |
1.014060E-02 |
| Caucasian-vs-AfricanAmerican |
3.710600E-01 |
| Caucasian-vs-Asian |
4.376200E-01 |
| AfricanAmerican-vs-Asian |
6.647600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.100500E-03 |
| Normal-vs-Female |
8.823200E-03 |
| Male-vs-Female |
8.461200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.992400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.101500E-03 |
| Normal-vs-Age(61-80Yrs) |
5.804100E-03 |
| Normal-vs-Age(81-100Yrs) |
6.645400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.081800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.914420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.540200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.834400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.549970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.823010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.359800E-01 |
| Classical-VS-Follicular |
6.409300E-04 |
| Classical-VS-Other |
7.053600E-02 |
| Classical-VS-Normal |
2.025700E-02 |
| Tall-VS-Follicular |
1.740770E-01 |
| Tall-VS-Other |
1.893390E-01 |
| Tall-VS-Normal |
4.993600E-02 |
| Follicular-VS-Other |
7.724200E-01 |
| Follicular-VS-Normal |
7.755800E-04 |
| Other-VS-Normal |
2.216400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.516870E-03 |
| Normal-vs-N1 |
2.368300E-02 |
| N0-vs-N1 |
1.414950E-01 |
|
|
